1 |
Khanal S, Attallah N, Smith DE : Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. The American journal of Medicine 2005; 118: 843-9.
DOI
ScienceOn
|
2 |
Gupta RK, Kapoor A, Tavani S : Captopril for the prevention of contrast media-induced nephropathy in diabetic patients: a randomized study. Indian Heart Journal 1999; 51: 521-6.
|
3 |
Thomas: Diuretics, ACE inhibitors and NSAIDS the triple whammy. The Medical Journal of Australia 2000; 172 (4): 184-5.
|
4 |
Peter C. Austin and Muhammad M. Mamdani : Impact of the pravastatin or atorvastatin evaluation and infection therapythrombolysis In myocardial infarction 22/reversal of atherosclerosis with aggressive lipid lowering trials on trends in intensive versus moderate statin therapy in ontario Canada. Circulation 2005; 112: 1296-1300.
DOI
ScienceOn
|
5 |
Smilde TJ, Wissen SV, Wollersheim H : Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. The Lancet 2001; 357: 577-81.
DOI
ScienceOn
|
6 |
Ridker PM, Danielson E, Fonseca FAH et al: Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. The New England Journal of Medicine 2008; 359: 2195-2207.
DOI
ScienceOn
|
7 |
Horowitz JD, Antman EM, Lorell BH, Barry WH, Smith TW : Potentiation of the cardiovascular effects of nitroglycerin by Nacetylcysteine. Circulation 1983; 68: 1247.
DOI
ScienceOn
|
8 |
Neumayer HH, Junge W, Kufner A, Wenning A: Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrology Dialysis Transplantation 1989; 4: 1030-6.
|
9 |
Winniford MD, Kennedy PL, Wells PJ, Hillis LD : Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation 1986; 73: 138.
DOI
ScienceOn
|
10 |
Loscalzo J : N-acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. Journal of Clinical Investigation 1985; 76: 703.
DOI
|
11 |
Berns AS: Nephrotoxicity of contrast media. Kidney international 1989; 36: 730-40.
DOI
ScienceOn
|
12 |
Isenbarger DW, Kent SM, O'Malley PG : Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. The American Journal of Cardiology 2003; 92: 1454-8.
DOI
ScienceOn
|
13 |
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W : Prevention of radiographic contrast-agent-induced reductions in renal function by acetylcysteine. The New England Journal of Medicine 2000; 343: 180-4.
DOI
ScienceOn
|
14 |
Parfrey PS, Griffiths SM, Barrett BJ : Contrast material - induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. The New England Journal of Medicine 1989; 320: 143-9.
DOI
ScienceOn
|
15 |
Solomon R : Contrast-medium-induced acute renal failure. Kidney International 1998; 53: 230-42.
DOI
ScienceOn
|
16 |
Nash K, Hafeez A, Hou S : Hospital-acquired renal insufficiency. American Journal of Kidney Diseases 2002; 39: 930-6.
DOI
ScienceOn
|
17 |
Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Semin Nephrol 1997; 17: 15-26.
|
18 |
Weisberg LS, Kurnik PB, Kurnik BR : Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney International 1994; 45: 259-265.
DOI
ScienceOn
|
19 |
Lautin EM, Freeman NJ, Schoenfeld AH : Radiocontrast associated renal dysfunction: incidence and risk factors. American Journal of Roentgenology 1991; 157: 49-58.
DOI
ScienceOn
|
20 |
Cohan RH, Dunnick NR: Intravascular contrast media: Adverse reactions. American Journal of Roentgenology 1987; 149: 665-70.
DOI
ScienceOn
|
21 |
Weisberg LS, Kurnik PB, Kurnik BR : Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney International 1994; 45: 259-65.
|
22 |
Barrett BJ : Contrast nephrotoxicity. Journal of the Amerian Society of Nephrology 1994; 5: 125-37.
|
23 |
McCullough PA, Soman SS: Contrast-induced nephropathy. Critical Care Clinics 2005; 21: 261-80.
DOI
ScienceOn
|
24 |
Murakami R, Machida M, Tajima H : Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography. Acta Radiol 2002; 43: 340-3.
DOI
ScienceOn
|
25 |
Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M : Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069-75.
DOI
ScienceOn
|
26 |
Aderson RA, Linda SL, Beanos AS, Enrich SL, Miller PR, Gallow PA, Scarier AW : Nonoliguric acute renal failure. The New England Journal of Medicine 1997; 296: 1134-8.
|
27 |
Schusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G : Risk factors and outcome of hospitalacquired acute renal failure. Clinical epidemiologic study. The American Journal of Cardiology 1987; 83: 65-71.
|
28 |
Sheridan AM, Bonventre JV : Pathophysiology of ischemic acute renal failure. Contributions to Nephrology 2001; 132: 7-21.
|
29 |
Bakris GL, Gaber AO, Jones JD : Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology 1990; 175: 57-60.
DOI
|
30 |
Hizoh I, Haller C : Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Investigational Radiology 2002; 37: 428-34.
DOI
ScienceOn
|
31 |
Safirstein R, Andrade L, Vieira JM: Acetylcysteine and nephrotoxic effects of radiographic contrast agents: a new use for an old drug. The New England Journal of Medicine 2000; 343: 210-212.
DOI
ScienceOn
|
32 |
DiMari J, Megyesi J, Udvarhelyi : N-acetylcysteine ameliorates ischemic renal failure. American Journal of Physiology 1997; 27: F292-8.
|
33 |
Briguori C, Colombo A, Airoldi F : N-acetylcysteine versus fenoldopam mesylate to prevent contrast agentassociated nephrotoxicity. Journal of the American College of Cardiology 2004; 44: 762-5.
DOI
ScienceOn
|
34 |
Koch JA, Plum J, Grabensee B, Modder U : Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrology Dialysis Transplantation 2000; 15: 43-9.
|
35 |
Grimm C, Wenzel A, Acar N l: Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Advances in Experimental Medicine and Biology 2006; 588: 119-31.
|
36 |
Gurkowski L, MacDougall M, Wiegmann T : Effects of misoprostol on contrast-induced renal dysfunction. American Journal of Therapeutics 1995; 2: 837-42.
DOI
ScienceOn
|
37 |
Erley CM, Duda SH, Schlepckow S : Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney International 1994; 45: 1425-31.
DOI
ScienceOn
|
38 |
Tada H, Kagaya Y, Takeda M : Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovascular Research 2006; 71; 466-77.
DOI
ScienceOn
|
39 |
Solomon R, Werner C, Mann D : Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. The New England Journal of Medicine 1994; 331: 1416-20.
DOI
ScienceOn
|
40 |
Gruberg L, Mintz GS, Mehran R : The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with preexistent chronic renal insufficiency. Journal of the American College of Cardiology 2000; 36: 1542-8.
DOI
ScienceOn
|
41 |
Cheon IS, Choi JH, Kim KL : Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Korean Circulation Journal 2004; 34: 1033-42.
DOI
|
42 |
Lee YS, Kim KS, Hyun DW : The change of arterial stiffness according to dialysis in patients with end-stage renal disease. Korean Circulation Journal 2004; 34: 865-73.
DOI
|
43 |
Mueller C, Buerkle G, Buettner HJ : Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Archives of Internal Medicine 2002; 162: 329-36.
DOI
ScienceOn
|
44 |
Barrett BJ, Carlisle EJ : Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-8.
DOI
|
45 |
Briguori C, Colombo A, Violante A : Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. European heart Journal 2004; 25: 206-11.
DOI
ScienceOn
|
46 |
Aspelin P, Aubry P, Fransson SG : Nephrotoxicity in highrisk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators : Nephrotoxic effects in high-risk patients undergoing angiography. The New England Journal of Medicine 2003; 348: 491-9.
DOI
ScienceOn
|
47 |
Arstall MA, Yang J, Stafford I : N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects. Circulation 1995; 92: 2855-62.
DOI
ScienceOn
|
48 |
Chung SR, Kim ES, Jung JY, Kim : The protective effect of recombinant human erythropoietin and N-acetylcysteine in radiocontrast-induced nephrotoxicity. The Korean Journal of nephrology 2007; 26: 699-704.
|